Selection and characterization of single-stranded DNA aptamers against interleukin-5

Mina Jamalvandi , Hossein Khanahmad , Shiva Irani, Sayad Bastaminezhad

Abstract


Asthma as a chronic inflammatory disorder is associated with many cytokines like interleukin-5 (IL-5)   which plays essential role in eosinophil differentiation and maturation. Accordingly, blockage of IL-5 using mepalizumab has been considered as a promising therapeutic approach for asthma. Despite the monocolonal antibody advantages, some restrictions provided an acceptable background for alternative agents like aptamers which could replace with antibodies. In the current study, aptamer isolation against IL-5 molecule was intended, according to the valuable benefits of aptamers over antibodies. HEK-293T/IL-5 cell was constructed to select aptamer using cell‐systematic evolution of ligands by exponential enrichment (SELEX) method. Integration of the IL-5 fragment to genome of the HEK-293T was verified by  polymerase chain reaction on the genomic DNA of the transfected cells. Moreover, IL-5 protein expression on the cell surface was confirmed using flow cytometry analysis. Then, cell SELEX was carried out in 12 rounds and isolated aptamers were evaluated by flow cytometry analysis. The selected clones were then sequenced and assessed for any possible secondary structure. The results of this study led to the selection of 19 different single‐stranded DNA clones after 12 rounds of selection which were clustered to five groups based on common structural motifs. In conclusion, the findings revealed the isolation of IL-5‐specific single‐stranded DNA aptamers, which can further be substituted with mepolizumab.


Keywords


Aptamer; Asthma; Cell-SELEX; HEK-293T; Interleukin-5.

Full Text:

PDF

References


Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009;360(10):973-984.

Menzella F, Lusuardi M, Galeone C, Taddei S, Facciolongo N, Zucchi L. Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential. Ther Adv Chronic Dis. 2016;7(6):260-277.

Flood-Page P, Swenson C, Faiferman I, Matthews J, Williams M, Brannick L, et al. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med. 2007;176(11):1062-1071.

Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med. 2003;167(2):199-204.

Miranda C, Busacker A, Balzar S, Trudeau J, Wenzel SE. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol. 2004;113(1):101-108.

Greenfeder S, Umland SP, Cuss FM, Chapman RW, Egan RW. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir Res. 2001;2(2):71-79.

Rothenberg, ME, Klion AD, Roufosse FE, Kahn JE, Weller PF, Simon HU, et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med. 2008;358(12): 1215-1228.

Shahbazi Dastjerdeh M, Kouhpayeh S, Sabzehei F, Khanahmad H, Salehi M, Mohammadi Z, et al. Zinc finger nuclease: a new approach to overcome beta-lactam antibiotic resistance. Jundishapur J Microbiol. 2016;9(1):e29384.

Modares Sadeghi M, Shariati L, Hejazi Z, Shahbazi M, Tabatabaiefar MA, Khanahmad H. Inducing indel mutation in the SOX6 gene by zinc finger nuclease for gamma reactivation: An approach towards gene therapy of beta thalassemia. J Cell Biochem. 2018;119(3): 2512-2519.

Shariati L, Modarressi MH, Tabatabaiefar MA, Kouhpayeh S, Hejazi Z, Shahbazi M, et al. Engineered zinc-finger nuclease to generate site-directed modification in the KLF1 gene for fetal hemoglobin induction. J Cell Biochem. 2018. DOI: 10.1002/jcb.28130. [Epub ahead of print]

Shariati L, Rohani F, Heidari Hafshejani N, Kouhpayeh S, Boshtam M, Mirian M, et al. Disruption of SOX6 gene using CRISPR/Cas9 technology for gamma-globin reactivation: An approach towards gene therapy of beta-thalassemia. J Cell Biochem. 2018;119(11):9357-9363.

Kouhpayeh S, Hejazi Z, Boshtam M, Mirian M, Rahimmanesh I, Darzi L, et al. Development of α4 integrin DNA aptamer as a potential therapeutic tool for multiple sclerosis. J Cell Biochem. 2019;120(9):16264-16272.

Sefah K, Shangguan D, Xiong X, O'Donoghue MB, Tan W. Development of DNA aptamers using Cell-SELEX. Nat Protoc. 2010;5(6):1169-1185.

Song KM, Lee S, Ban C. Aptamers and their biological applications. Sensors (Basel). 2012;12(1):612-631.

Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature, 1990;346(6287):818-822.

Mirian M, Taghizadeh R, Khanahmad H, Salehi M, Jahanian-Najafabadi A, Sadeghi-Aliabadi H, et al. Exposition of hepatitis B surface antigen (HBsAg) on the surface of HEK293T cell and evaluation of its expression. Res Pharm Sci. 2016;11(5):366-373.

Fang X, Tan W. Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc Chem Res. 2010;43(1):48-57.

Thomas P, Smart TG. HEK293 cell line: a vehicle for the expression of recombinant proteins. J Pharmacol Toxicol Methods. 2005;51(3):187-200.

Portolano N, Watson PJ, Fairall L, Millard CJ, Milano CP, Song Y, et al. Recombinant protein expression for structural biology in HEK 293F suspension cells: a novel and accessible approach. J Vis Exp. 2014;92:e51897. 8 pages.

Naderi Beni Sh, Kouhpayeh Sh, Hejazi Z, Heidari Hafshejani N, Khanahmad H. Construction and characterization of recombinant HEK cell over expressing α4 integrin. Adv Pharm Bull. 2015;5(3):429-434.

Boshtam M, Asgary S, Rahimmanesh I, Kouhpayeh S, Naderi J, Hejazi Z, et al. Display of human and rabbit monocyte chemoattractant protein-1 on human embryonic kidney 293T cell surface. Res Pharm Sci. 2018;13(5):430-439.

Rahimmanesh I, Khanahmad H, Boshtam M, Kouhpayeh Sh, Hejazi Z. Cell surface display of rabbit MCP1 on human embryonic kidney 293T cell line. Indian J Biotechnol. 2017;16(3):284-288.

Ebrahimi M, Kazemi T, Ganjalikhani-Hakemi M, Majidi J, Khanahmad H, Rahimmanesh I, et al. Development of a stable cell line, overexpressing human T-cell immunoglobulin mucin 1. Iran J Biotechnol. 2015;13(4):25-31.

Bruun TH, Grassmann V, Zimmer B, Asbach B, Peterhoff D, Kliche A, et al. Mammalian cell surface display for monoclonal antibody-based FACS selection of viral envelope proteins. mAbs. 2017;9(7):1052-1064.

Bowers PM, Horlick RA, Kehry MR, Neben TY, Tomlinson GL, Altobell L, et al, Mammalian cell display for the discovery and optimization of antibody therapeutics. Methods. 2014;65(1):44-56.

Aricescu AR, Owens RJ. Expression of recombinant glycoproteins in mammalian cells: towards an integrative approach to structural biology. Curr Opin Struct Biol. 2013;23(3):345-356.

Zhu J. Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv. 2012;30(5):1158-1170.

Faryammanesh R, Lange T, Magbanua E, Haas S, Meyer C, Wicklein D, et al. SDA, a DNA aptamer inhibiting E- and P-selectin mediated adhesion of cancer and leukemia cells, the first and pivotal step in transendothelial migration during metastasis formation. PLoS One. 2014;9(4):e93173. 8 pages.

Berg K, Lange T, Mittelberger F, Schumacher U, Hahn U. Selection and characterization of an α6β4 integrin blocking DNA aptamer. Mol Ther Nucleic Acids. 2016;5:e294. 7 pages.

Hui Y, Shan L, Lin-Fu Z, Jian-Hua Z. Selection of DNA aptamers against DC-SIGN protein. Mol Cell Biochem. 2007;306(1-2):71-77.

Blind M, Kolanus W, Famulok M. Cytoplasmic RNA modulators of an inside-out signal-transduction cascade. Proc Natl Acad Sci U S A. 1999;96(7):3606-3610.

Zhou J, Rossi JJ. Cell-specific aptamer-mediated targeted drug delivery. Oligonucleotides. 2011;21(1):1-10.

Kim JW, Kim EY, Kim SY, Byun SK, Lee D, Oh KJ, et al. Identification of DNA aptamers toward epithelial cell adhesion molecule via cell-SELEX. Mol Cells. 2014;37(10):742-746.

Arap W, Kolonin MG, Trepel M, Lahdenranta J, Cardó-Vila M, Giordano RJ, et al. Steps toward mapping the human vasculature by phage display. Nat Med. 2002;8(2):121-127.

Orava EW, Jarvik N, Shek YL, Sidhu SS, Gariépy J. A short DNA aptamer that recognizes TNFα and blocks its activity in vitro. ACS Chem Biol. 2013;8(1):170-178.

Berezhnoy A, Stewart CA, Mcnamara JO, Thiel W, Giangrande P, Trinchieri G, et al. Isolation and optimization of murine IL-10 receptor blocking oligonucleotide aptamers using high-throughput sequencing. Mol Ther. 2012;20(6):1242-1250.

Cao B, Hu Y, Duan J, Ma J, Xu D, Yang XD. Selection of a novel DNA aptamer for assay of intracellular interferon-gamma. PLoS One. 2014;9(5):e98214.

Gupta S, Hirota M, Waugh SM, Murakami I, Suzuki T, Muraguchi M, et al. Chemically modified DNA aptamers bind interleukin-6 with high affinity and inhibit signaling by blocking its interaction with interleukin-6 receptor. J Biol Chem. 2014;289(12):8706-8719.

Liu Y, Zhou Q, Revzin A. An aptasensor for electrochemical detection of tumor necrosis factor in human blood. Analyst. 2013;138(15):4321-4326.

Meyer C, Eydeler K, Magbanua E, Zivkovic T, Piganeau N, Lorenzen I, et al. Interleukin-6 receptor specific RNA aptamers for cargo delivery into target cells. RNA Biol. 2012;9(1):67-80.

Stoltenburg R, Nikolaus N, Strehlitz B. Capture-SELEX: selection of DNA aptamers for aminoglycoside antibiotics. J Anal Methods Chem. 2012;2012. Article ID 415697, 14 pages.

Kinghorn AB, Fraser LA, Lang S, Shiu SCC, Tanner JA. Aptamer bioinformatics. Int J Mol Sci. 2017;18(12). pii: E2516. 22 pages.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.